FXH

First Trust Health Care AlphaDEX Fund

Up$72.70
+$0.32
(+0.44%)
As of 12:00:00 AM EDT | 5/24/19  |  Market Closed

FXH Trading Data

Open

$72.64

Low Price

$72.45

High Price

$73.15

Previous Last Price

$72.38

Bid Size

$0 X 0

Ask Size

$0 X 0

FXH Portfolio Data

AUM

$1,143,130,000

Shares

15,800

PE Ratio

21.32

Price / Book Ratio

3.33

Expense Ratio

0.63

Net Asset Value

$72.35

Volume

Volume

114,200

Avg. Volume (YDT)

350,745

Dollar Volume

$7,239,576

Weekly Avg. Volume

133,220

Monthly Avg. Volume

264,625

Quarterly Avg. Volume

428,120

FXH Fund Description

The First Trust Health Care AlphaDEX Fund is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before fees and expenses, of an equity index called the StrataQuant Health Care Index. The gross expense ratio for this fund is 0.61%. Expenses are capped contractually at 0.70% per year, at least until November 30, 2017.

FXH Chart

FXH Summary

Fund Family

First Trust Portfolios

Tracks This Index

First Trust Health Care AlphaDEX Fund

Inception Date

2007-05-08

Asset Class

Equity

Asset Class Size

Biotech

FXH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

FXH Holdings

Top 10 Holdings

Veeva Systems Inc. (Class A) (VEEV)
2.78%
Bruker Corporation (BRKR)
2.74%
Exact Sciences Corporation (EXAS)
2.72%
Thermo Fisher Scientific Inc. (TMO)
2.48%
Biogen Inc. (BIIB)
2.43%
Bio-Rad Laboratories Inc. (Class A) (BIO)
2.41%
MEDNAX Inc. (MD)
2.38%
Incyte Corporation (INCY)
2.35%
Varian Medical Systems Inc. (VAR)
2.25%
Charles River Laboratories International Inc. (CRL)
2.22%

Total FXH Holdings

Total Holdings: 75

Veeva Systems Inc. (Class A) (VEEV)
2.78%
Bruker Corporation (BRKR)
2.74%
Exact Sciences Corporation (EXAS)
2.72%
Thermo Fisher Scientific Inc. (TMO)
2.48%
Biogen Inc. (BIIB)
2.43%
Bio-Rad Laboratories Inc. (Class A) (BIO)
2.41%
MEDNAX Inc. (MD)
2.38%
Incyte Corporation (INCY)
2.35%
Varian Medical Systems Inc. (VAR)
2.25%
Charles River Laboratories International Inc. (CRL)
2.22%
Exelixis Inc. (EXEL)
2.08%
Ionis Pharmaceuticals Inc. (IONS)
2.07%
PRA Health Sciences Inc. (PRAH)
1.99%
Celgene Corporation (CELG)
1.9%
WellCare Health Plans Inc. (WCG)
1.9%
Bio-Techne Corporation (TECH)
1.86%
Masimo Corporation (MASI)
1.86%
The Cooper Companies Inc. (COO)
1.84%
United Therapeutics Corporation (UTHR)
1.84%
Teleflex Incorporated (TFX)
1.81%
Stryker Corporation (SYK)
1.75%
Seattle Genetics Inc. (SGEN)
1.74%
Alexion Pharmaceuticals Inc. (ALXN)
1.73%
Penumbra Inc. (PEN)
1.72%
Universal Health Services Inc. (Class B) (UHS)
1.72%
Molina Healthcare Inc. (MOH)
1.68%
Edwards Lifesciences Corporation (EW)
1.66%
Laboratory Corporation of America Holdings (LH)
1.63%
Quest Diagnostics Incorporated (DGX)
1.63%
Gilead Sciences Inc. (GILD)
1.55%
Zoetis Inc. (ZTS)
1.54%
Elanco Animal Health Incorporated (ELAN)
1.52%
Bristol-Myers Squibb Company (BMY)
1.49%
HCA Healthcare Inc. (HCA)
1.46%
Jazz Pharmaceuticals Plc (JAZZ)
1.45%
bluebird bio Inc. (BLUE)
1.44%
Becton Dickinson and Company (BDX)
1.41%
Baxter International Inc. (BAX)
1.39%
Hill-Rom Holdings Inc. (HRC)
1.37%
Eli Lilly and Company (LLY)
1.35%
DaVita Inc. (DVA)
1.33%
Mylan N.V. (MYL)
1.27%
Intuitive Surgical Inc. (ISRG)
1.25%
Cerner Corporation (CERN)
1.14%
Catalent Inc. (CTLT)
1.06%
Insulet Corporation (PODD)
1.04%
Align Technology Inc. (ALGN)
1.01%
Chemed Corporation (CHE)
0.97%
Medtronic Plc (MDT)
0.94%
Perrigo Company Plc (PRGO)
0.93%
UnitedHealth Group Incorporated (UNH)
0.93%
Boston Scientific Corporation (BSX)
0.92%
Pfizer Inc. (PFE)
0.92%
Merck & Co. Inc. (MRK)
0.91%
Amgen Inc. (AMGN)
0.85%
Integra LifeSciences Holdings Corporation (IART)
0.82%
Agilent Technologies Inc. (A)
0.79%
Regeneron Pharmaceuticals Inc. (REGN)
0.72%
IDEXX Laboratories Inc. (IDXX)
0.53%
Centene Corporation (CNC)
0.49%
Premier Inc. (Class A) (PINC)
0.49%
West Pharmaceutical Services Inc. (WST)
0.49%
AmerisourceBergen Corporation (ABC)
0.47%
Illumina Inc. (ILMN)
0.47%
Johnson & Johnson (JNJ)
0.47%
Humana Inc. (HUM)
0.46%
Sarepta Therapeutics Inc. (SRPT)
0.46%
Anthem Inc. (ANTM)
0.45%
DexCom Inc. (DXCM)
0.45%
Cigna Corporation (CI)
0.44%
Vertex Pharmaceuticals Incorporated (VRTX)
0.44%
Neurocrine Biosciences Inc. (NBIX)
0.42%
Agios Pharmaceuticals Inc. (AGIO)
0.34%
Morgan Stanley Institutional Liquidity Fund - Treasury Portfolio (MISXX)
0.25%
First Trust Health Care AlphaDEX Fund (FXH)
0%

FXH Technicals

Alpha

-1.3

Beta

1.12

Leverage

Long

Standard Deviation

3.97

FXH Dividends

Dividend Date

2013-06-21

Latest Dividend

0.0055

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

FXH Performance

YTD Return

5.56%

1 Year Return

-0.41%

3 Year Return

24.64%

5 Year Return

40.67%

10 Year Return

362.17%

FXH Related Articles